Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Y61
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,185
Award facts
- Contract value 100% obligated
- $27,184.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $27,184.50 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price contract with an ultimate completion date of January 20, 2026, issued on January 16, 2026. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of Cencora, Inc., and serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle running through December 2026 that provides comprehensive global pharmaceutical support across multiple therapeutic domains. The IDC enables the contractor to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Dupixent, a specialty pharmaceutical indicated for atopic dermatitis and other inflammatory conditions, represents the type of specialty medication critical to military medical supply chains that this prime vendor contract is designed to facilitate.
Quick answers
Who was awarded contract SPE2DR26F9Y61?
SPE2DR26F9Y61 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9Y61 worth?
The government has obligated $27,185 on SPE2DR26F9Y61.
Is contract SPE2DR26F9Y61 an order under another contract?
Yes. SPE2DR26F9Y61 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Y61 competed?
The extent of competition for SPE2DR26F9Y61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award